Obama stand-in & GOP presidential hopeful Vivek Ramaswamy founded Roivant in 2014 with the idea of acquiring drug candidates that large pharmaceutical companies had partially developed; helmed the company as CEO before stepping down in early 2021. It’s the first time Ramaswamy has sold 4 million shares of Roivant at a price of $7.95 per share for a total of $32 million, since the biotech holding firm went public in October 2021. The stock sale, came one day after Ramaswamy announced his longshot bid for the Republican presidential candidacy.